Our Pricing

Switch & Save: Where to Buy Wegovy in the UK Today

Published on: June 03, 2026

If you're wondering where to buy Wegovy in the UK with transparent pricing and genuine clinical support, Cured Pharmacy offers UK-licensed Wegovy pens from £79.00 with a free online consultation completed in under three minutes. Our UK-registered prescribers assess every patient individually, ensuring safe, compliant access to this MHRA-licensed semaglutide treatment.

Understanding Wegovy: How Semaglutide Works for Weight Loss

Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics a natural hormone your body produces after eating. This medication works by slowing gastric emptying, reducing appetite signals in the brain, and improving blood sugar regulation—three mechanisms that together support clinically significant weight reduction [1].

In the landmark STEP 1 trial, adults using Wegovy alongside lifestyle modifications achieved an average 14.9% body weight reduction over 68 weeks, compared to 2.4% with placebo [1]. These results led to MHRA licensing and NICE guidance recommending semaglutide for weight management in eligible UK patients with a BMI of 30 or above, or 27 with weight-related comorbidities [2].

As a once-weekly subcutaneous injection, Wegovy offers convenience compared to daily treatments. The dose escalates gradually over 16-20 weeks, starting at 0.25mg and increasing to a maintenance dose of 2.4mg weekly, which helps minimise gastrointestinal side effects during the adjustment period [3].

Why Choose Cured Pharmacy for Your Wegovy Prescription

At Cured Pharmacy, we're a fully registered UK pharmacy (GPhC Registration Number 9012511) under the supervision of Superintendent Pharmacist Tarun Kumar (GPhC 2233073). Every Wegovy prescription is assessed by our UK-registered clinical team, ensuring you receive appropriate care that meets General Pharmaceutical Council standards.

Our transparent pricing model shows you the exact cost before you begin your consultation—no hidden fees, no surprise charges at checkout. We guarantee the lowest prices in the UK for genuine, licensed medicines sourced directly from UK-approved wholesalers. All packaging is 100% discreet, with no external branding or product descriptions visible.

The online consultation takes under three minutes to complete and covers your medical history, current medications, and weight loss goals. If our prescriber determines Wegovy is clinically appropriate for you, your prescription is fulfilled and dispatched for next-day delivery across the UK.

What Makes Our Service Different

Unlike some online services that operate from overseas or use non-UK prescribers, every clinical decision at Cured Pharmacy is made by GMC-registered doctors working within UK regulatory frameworks. You'll have access to ongoing support throughout your treatment journey, with the ability to contact our pharmacy team on (+44) 116 4646009 during business hours for any questions about your medication.

Wegovy Pricing and What's Included in Your Treatment

Wegovy is available at Cured Pharmacy from £79.00 per pen, representing a £79.00 saving compared to our standard pricing. The cost covers your medication, clinical consultation, prescription processing, and discreet home delivery. There are no additional consultation fees or membership charges—the price you see is the price you pay.

Your prescription will specify the appropriate dose based on where you are in the titration schedule. Most patients begin with the 0.25mg starter dose and progress through 0.5mg, 1mg, and 1.7mg doses before reaching the 2.4mg maintenance dose. Our prescribers will guide you through this escalation protocol during your assessment.

Each pen contains four weekly doses at the lower strengths, or a single dose at the 2.4mg maintenance level. Your prescriber will provide clear instructions on injection technique, storage requirements (refrigeration between 2-8°C), and what to expect during the first few weeks of treatment.

Payment and Delivery Options

We accept all major credit and debit cards through secure payment processing. Once your prescription is approved, orders placed before 3pm are dispatched the same working day via Royal Mail tracked delivery. You'll receive tracking information by email, and most UK addresses receive their medication within 24 hours of dispatch.

Comparing Weight Loss Treatments: Finding Your Best Option

While Wegovy remains the most widely prescribed GLP-1 treatment for weight management in the UK, several other licensed options exist depending on your clinical needs and treatment preferences. Understanding the differences helps you have an informed discussion with your prescriber about which medication may suit you best.

Mounjaro (tirzepatide) is a newer dual GIP/GLP-1 receptor agonist that demonstrated higher average weight loss in head-to-head trials—up to 22.5% body weight reduction in the SURPASS-3 study [4]. However, it's currently licensed in the UK for type 2 diabetes, with weight management licensing expected following MHRA review. Some prescribers may consider it off-label for weight loss in appropriate patients.

Saxenda (liraglutide) is a daily injection that's been available longer than Wegovy and uses an earlier-generation GLP-1 molecule. Clinical trials showed average weight loss of 8% over 56 weeks [5]—lower than semaglutide but still clinically meaningful for many patients. The daily injection schedule requires more frequent administration but allows for easier dose adjustment.

Oral medications like Orlistat and Mysimba work through entirely different mechanisms—Orlistat blocks fat absorption in the gut, while Mysimba combines naltrexone and bupropion to reduce cravings. These may be appropriate alternatives if injectable treatments aren't suitable for your circumstances.

Who Can Use Wegovy: Eligibility and Clinical Considerations

NICE guidelines recommend considering GLP-1 treatments like Wegovy for adults with a BMI of 30 kg/m² or above, or 27 kg/m² with at least one weight-related comorbidity such as type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea, or cardiovascular disease [2]. Your prescriber will calculate your BMI during the consultation and assess whether you meet clinical criteria.

Wegovy is not suitable for everyone. Contraindications include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, pregnancy or breastfeeding, and severe gastrointestinal disease. Your prescriber will review your full medical history to identify any factors that would make semaglutide inappropriate for you.

Common side effects include nausea, diarrhoea, vomiting, constipation, and abdominal pain, particularly during dose escalation [3]. These effects typically diminish as your body adjusts to the medication. More serious but rare risks include pancreatitis, gallbladder problems, and hypoglycaemia in patients taking certain diabetes medications. Your prescriber will discuss these risks and provide guidance on recognising warning signs.

Lifestyle Modifications Alongside Medication

Wegovy is licensed for use alongside reduced-calorie diet and increased physical activity—not as a standalone treatment. Clinical trials that demonstrated significant weight loss included structured lifestyle intervention programmes [1]. Your prescriber may recommend resources for nutritional guidance and exercise planning to optimise your results. Most patients find the appetite suppression from semaglutide makes dietary changes easier to sustain than previous attempts without medication.

How to Start Your Wegovy Treatment at Cured Pharmacy

Beginning your weight loss journey with Wegovy takes just a few simple steps. First, complete our online medical questionnaire, which asks about your weight history, current health conditions, medications you're taking, and previous weight loss attempts. This information helps our prescribers make an informed clinical decision about your suitability for semaglutide treatment.

A UK-registered prescriber will review your consultation within hours during working days. If Wegovy is deemed appropriate and safe for you, they'll issue an NHS-valid private prescription and send it directly to our dispensing team. If there are any concerns or if additional information is needed, the prescriber will contact you before proceeding.

Once your prescription is processed, our pharmacy team prepares your medication for dispatch. You'll receive an email confirmation with tracking details, and your Wegovy pens will arrive in plain, unmarked packaging with no indication of contents. The package includes patient information leaflets, injection instructions, and contact details for our pharmacy team should you have any questions during your treatment.

Follow-up consultations are available as you progress through the dose escalation schedule. Many patients benefit from regular check-ins to monitor progress, adjust doses, and address any side effects. Our clinical team can arrange ongoing prescriptions once you reach your maintenance dose, ensuring continuity of care throughout your weight loss programme.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., & Kushner, R. F. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity [TA875]. NICE. https://www.nice.org.uk/guidance/ta875 [accessed 13 August 2026]
3. Electronic Medicines Compendium. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Medicines.org.uk. https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
4. Ludvik, B., Giorgino, F., Jódar, E., Frias, J. P., Fernández Landó, L., Brown, K., Bray, R., & Rodríguez, Á. (2021). Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial. The Lancet, 398(10300), 583–598. https://doi.org/10.1016/S0140-6736(21)01443-4 [accessed 13 August 2026]
5. Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., Lau, D. C., le Roux, C. W., Violante Ortiz, R., Jensen, C. B., & Wilding, J. P. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Wegovy is a prescription-only medicine and may not be suitable for everyone. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary—clinical trial data represents average outcomes and does not guarantee specific results for any patient.